The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

ResMed Inc

NYSE: RMD
Last

(U.S.) $58.13

Today's change0.00 0.00%
Updated May 24 4:02 PM EDT. Delayed by at least 15 minutes.
 

ResMed Inc

NYSE: RMD
Last

(U.S.) $58.13

Today's change0.00 0.00%
Updated May 24 4:02 PM EDT. Delayed by at least 15 minutes.

ResMed Inc closed at (U.S.)$58.13.

Over the last five days, shares have gained 1.57% and 8.27% year to date. Shares have outperformed the S&P 500 by 4.19% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $58.13
  • High--
  • Low--
  • Bid / Ask(U.S.) $50.55 / (U.S.) $200.00K
  • YTD % change+8.27%
  • Volume0
  • Average volume (10-day)668,960
  • Average volume (1-month)896,695
  • Average volume (3-month)1,117,388
  • 52-week range(U.S.) $48.99 to (U.S.) $61.23
  • Beta0.65
  • Trailing P/E23.76×
  • P/E 1 year forward21.94×
  • Forward PEG2.09×
  • Indicated annual dividend(U.S.) $1.20
  • Dividend yield2.06%
  • Trailing EPS(U.S.) $2.45
Updated May 24 4:02 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.00%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue454455412453
Total other revenue--------
Total revenue454455412453
Gross profit260267239259
Total cost of revenue194188173194
Total operating expense350347314354
Selling / general / administrative123118111129
Research & development28292729
Depreciation / amortization5422
Interest expense (income), net operating--------
Unusual expense (income)07--0
Other operating expenses, total--------
Operating income10410898100
Interest income (expense), net non-operating-------6
Gain (loss) on sale of assets--------
Other--------
Income before tax10911499104
Income after tax88918087
Income tax, total21231917
Net income88918087
Total adjustments to net income--------
Net income before extra. items88918087
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items88918087
Inc. avail. to common incl. extra. items88918087
Diluted net income88918087
Dilution adjustment--------
Diluted weighted average shares141141142143
Diluted EPS excluding extraordinary itemsvalue per share0.630.640.570.61
Dividends per sharevalue per share0.300.300.300.28
Diluted normalized EPSvalue per share0.630.680.570.61